📘 Pfizer manuals • Free online PDFs

Pfizer Manuals & User Guides

User manuals, setup guides, troubleshooting help, and repair information for Pfizer products.

Tip: include the full model number printed on your Pfizer label for the best match.

About Pfizer manuals on Manuals.plus

Llawlyfrau Defnyddwyr, Cyfarwyddiadau a Chanllawiau ar gyfer cynhyrchion Pfizer.

Pfizer manuals

Llawlyfrau diweddaraf gan manuals+ wedi'i guradu ar gyfer y brand hwn.

Llawlyfr Cyfarwyddiadau Tabled Pfizer Quinapril 5 mg

Tachwedd 18, 2025
Pfizer Quinapril 5 mg Tablet WARNING: FETAL TOXICITY When pregnancy is detected, discontinue ACCUPRIL as soon as possible. Drugs that act directly on the renin-angiotensin system can cause injury and…

Canllaw Defnyddiwr Rheoli Adwaith Niweidiol Pfizer

Hydref 10, 2024
Pfizer Adverse Reaction Management Management of Cytokine Release Syndrome (CRS) Identify CRS based on clinical presentation. Evaluate and treat other causes of fever, hypoxia, and hypotension. If CRS is suspected,…

Canllaw Defnyddiwr Meddalwedd Pfizer BEQVEZ

Mai 6, 2024
Pfizer BEQVEZ Software Specifications Product Name: BEQVEZTM (fidanacogene elaparvovec-dzkt) injection Initial U.S. Approval: 2024 Indicated for: Adults with moderate to severe hemophilia B (congenital factor IX deficiency) Indications and Usage:…

MEDROL 4mg Tablets by Pfizer User Guide

Chwefror 26, 2026
MEDROL 4mg Tablets by Pfizer Specifications Chemical Name: Methylprednisolone Molecular Weight: 374.48 Available Tablet Strengths: 2 mg, 4 mg, 8 mg, 16 mg, 32 mg Inactive Ingredients: 2 mg Tablet:…

CLEOCIN PHOSPHATE® (Clindamycin Injection, USP) Prescribing Information

Gwybodaeth Rhagnodi
Detailed prescribing information for CLEOCIN PHOSPHATE® (clindamycin injection, USP), an antibiotic used for serious bacterial infections. Covers indications, contraindications, warnings (including C. difficile-associated diarrhea and benzyl alcohol toxicity), dosage, administration,…

TRAZIMERA (trastuzumab-qyyp) Prescribing Information

Gwybodaeth Rhagnodi
TRAZIMERA (trastuzumab-qyyp) is a biosimilar to HERCEPTIN, indicated for the treatment of HER2-overexpressing breast cancer and HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma. It carries significant warnings for cardiomyopathy, infusion…